Evaluation of right coronary vascular dysfunction in severe pulmonary hypertensive rats using synchrotron radiation microangiography

Author:

Inagaki Tadakatsu1ORCID,Pearson James T.23ORCID,Tsuchimochi Hirotsugu2,Schwenke Daryl O.4,Saito Shigeyoshi5,Higuchi Takahiro67,Masaki Takeshi18,Umetani Keiji9,Shirai Mikiyasu210,Nakaoka Yoshikazu18ORCID

Affiliation:

1. Department of Vascular Physiology, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan

2. Department of Cardiac Physiology, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan

3. Biomedicine Discovery Institute and Department of Physiology, Monash University, Clayton, Australia

4. Department of Physiology Heart-Otago, University of Otago, Dunedin, New Zealand

5. Department of Bio_Medical Imaging, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan

6. Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

7. Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany

8. Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan

9. Japan Synchrotron Radiation Research Institute, Harima, Japan

10. Department of Advanced Medical Research for Pulmonary Hypertension, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan

Abstract

We demonstrated for the first time the impairment of vascular responses in the right coronary artery (RCA) of the dysfunctional right heart in pulmonary hypertensive rats in vivo. Treatment with an endothelin-1 receptor antagonist ameliorated vascular dysfunction in the RCA, enabled tissue remodeling of the right heart, and improved cardiac function. Our results suggest that impaired RCA function might also contribute to the early progression to heart failure in patients with severe pulmonary arterial hypertension (PAH). The endothelium of the coronary vasculature might be considered as a potential target in treatments to prevent heart failure in severe patients with PAH.

Funder

GlaxoSmithKline Japan

MEXT | Japan Society for the Promotion of Science

Publisher

American Physiological Society

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3